FLCN and Birt-Hogg-Dube syndrome: Nearly all germline BHD mutations are truncating, and RCC from BHD patients exhibit loss of heterozygosity of chromosome 17p [14], [19], [20], consistent with the hypothesis that BHD is a tumor suppressor gene.